Spheroidal Mesenchymal Stem Cells in Retinitis Pigmentosa
Retinitis Pigmentosa, Stem Cell Transplant
About this trial
This is an interventional supportive care trial for Retinitis Pigmentosa focused on measuring Retinitis pigmentosa, Mesenchymal stem cells, Spheroids, Suprachoroidal implantation
Eligibility Criteria
Inclusion Criteria: 1) Clinical and genetic diagnosis of Retinitis Pigmentosa Exclusion Criteria: Coexisting ocular pathology that may affect visual acuity, visual field and retinal morphology such as glaucoma, uveitis, previous vitreoretinal surgery, Coexisting cataract that may affect mfERG, visual field and/or ocular imaging, Refractive error that may affect measurements higher than +6.00D, lower than -6.00D Coexisting systemic diseases that may affect visual function such as diabetes, vasculitis, rheumatological diseases and chronic immunosuppressive use, Periocular injection of platelet-rich blood and transcorneal electrical stimulation in previous 6 months and 6) previous ocular surgery
Sites / Locations
- Acıbadem University
Arms of the Study
Arm 1
Experimental
Retinitis Pigmentosa patients
Suprachoroidal mesenchymal stem cell implanted Retinitis pigmentosa patients